Cervical Cancer Global Clinical Trials Review, H2, 2012

Pages: 115 Published: December 01, 2012 Report Code: GDHC1500CTIDB

  • Overview
  • Contents
  • Tables
  • Figures
  • Listen
    english text to speech voices

GlobalData's clinical trial report, “Cervical Cancer Global Clinical Trials Review, H2, 2012" provides data on the Cervical Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cervical Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cervical Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

– Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

– Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to Buy

– Understand the dynamics of a particular indication in a condensed manner

– Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

– Obtain discontinued trial listing for trials across the globe

– Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 6

Introduction 7

Cervical Cancer 7

Report Guidance 7

Clinical Trials by Region 8

Clinical Trials by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Five Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by BRIC Nations 16

Clinical Trials by G7 Nations 17

Clinical Trials in G7 Nations by Trial Status 18

Clinical Trials by E7 Nations 19

Clinical Trials in E7 Nations by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Unaccomplished Trials of Cervical Cancer 24

Subjects Recruited Over a Period of Time 31

Prominent Sponsors 32

Top Companies Participating in Cervical Cancer Therapeutics Clinical Trials 34

Prominent Drug Comparison 36

Clinical Trial Profiles 37

Clinical Trial Overview of Top Companies 37

GlaxoSmithKline plc 37

Clinical Trial Overview of GlaxoSmithKline plc 37

Merck & Co., Inc. 41

Clinical Trial Overview of Merck & Co., Inc. 41

Advaxis, Inc. 43

Clinical Trial Overview of Advaxis, Inc. 43

Eli Lilly and Company 44

Clinical Trial Overview of Eli Lilly and Company 44

Pfizer Inc. 45

Clinical Trial Overview of Pfizer Inc. 45

Helix BioPharma Corp. 46

Clinical Trial Overview of Helix BioPharma Corp. 46

Photocure ASA 47

Clinical Trial Overview of Photocure ASA 47

Zeria Pharmaceutical Co Ltd 48

Clinical Trial Overview of Zeria Pharmaceutical Co Ltd 48

Kirax Corporation 49

Clinical Trial Overview of Kirax Corporation 49

N.V. Mithra Pharmaceuticals S.A. 50

Clinical Trial Overview of N.V. Mithra Pharmaceuticals S.A. 50

Preventive Oncology International Inc 51

Clinical Trial Overview of Preventive Oncology International Inc 51

Novartis Pharmaceuticals Corporation 52

Clinical Trial Overview of Novartis Pharmaceuticals Corporation 52

MannKind Corporation 53

Clinical Trial Overview of MannKind Corporation 53

Taiho Pharmaceutical Co., Ltd. 54

Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd. 54

Bristol-Myers Squibb Company 55

Clinical Trial Overview of Bristol-Myers Squibb Company 55

Nippon Kayaku Co., Ltd. 56

Clinical Trial Overview of Nippon Kayaku Co., Ltd. 56

Novartis AG 57

Clinical Trial Overview of Novartis AG 57

Precision Therapeutics, Inc. 58

Clinical Trial Overview of Precision Therapeutics, Inc. 58

Hoffmann-La Roche Inc. 59

Clinical Trial Overview of Hoffmann-La Roche Inc. 59

Daiichi Sankyo Company, Limited 60

Clinical Trial Overview of Daiichi Sankyo Company, Limited 60

Clinical Trial Overview of Top Universities / Institutes / Hospitals 61

The University of Texas M. D. Anderson Cancer Center 61

Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 61

National Taiwan University Hospital 64

Clinical Trial Overview of National Taiwan University Hospital 64

University Health Network 66

Clinical Trial Overview of University Health Network 66

Memorial Sloan Kettering Cancer Center 67

Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 67

Tata Memorial Hospital 69

Clinical Trial Overview of Tata Memorial Hospital 69

Case Comprehensive Cancer Center 70

Clinical Trial Overview of Case Comprehensive Cancer Center 70

Medical University of Vienna 71

Clinical Trial Overview of Medical University of Vienna 71

University of California, Irvine 72

Clinical Trial Overview of University of California, Irvine 72

Duke University 73

Clinical Trial Overview of Duke University 73

Washington University School of Medicine 74

Clinical Trial Overview of Washington University School of Medicine 74

The University of Hong Kong 75

Clinical Trial Overview of The University of Hong Kong 75

Dana-Farber Cancer Institute 76

Clinical Trial Overview of Dana-Farber Cancer Institute 76

Wake Forest University 77

Clinical Trial Overview of Wake Forest University 77

Fred Hutchinson Cancer Research Center 78

Clinical Trial Overview of Fred Hutchinson Cancer Research Center 78

Abramson Cancer Center 79

Clinical Trial Overview of Abramson Cancer Center 79

Masonic Cancer Center 80

Clinical Trial Overview of Masonic Cancer Center 80

University of California, San Francisco 81

Clinical Trial Overview of University of California, San Francisco 81

The University of British Columbia 82

Clinical Trial Overview of The University of British Columbia 82

Chang Gung Memorial Hospital 83

Clinical Trial Overview of Chang Gung Memorial Hospital 83

Korea Cancer Center Hospital 84

Clinical Trial Overview of Korea Cancer Center Hospital 84

Five Key Clinical Profiles 85

Appendix 111

Abbreviations 111

Definitions 111

Research Methodology 113

Secondary Research 113

About GlobalData 114

Contact Us 114

Disclaimer 114

Source 115

List of Tables

Cervical Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8

Cervical Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9

Cervical Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10

Cervical Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11

Cervical Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12

Cervical Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 13

Cervical Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 14

Cervical Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 15

Cervical Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 16

Cervical Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 17

Cervical Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18

Cervical Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 19

Cervical Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20

Cervical Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21

Cervical Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22

Cervical Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23

Cervical Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24

Cervical Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25

Cervical Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27

Cervical Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 31

Cervical Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 33

Cervical Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 35

Cervical Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 36

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 37

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 41

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Advaxis, Inc., 2012* 43

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 44

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 45

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Helix BioPharma Corp., 2012* 46

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Photocure ASA, 2012* 47

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeria Pharmaceutical Co Ltd, 2012* 48

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kirax Corporation, 2012* 49

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by N.V. Mithra Pharmaceuticals S.A., 2012* 50

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Preventive Oncology International Inc, 2012* 51

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Pharmaceuticals Corporation, 2012* 52

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by MannKind Corporation, 2012* 53

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2012* 54

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 55

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Nippon Kayaku Co., Ltd., 2012* 56

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 57

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Precision Therapeutics, Inc., 2012* 58

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoffmann-La Roche Inc., 2012* 59

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2012* 60

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 61

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012* 64

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012* 66

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 67

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Tata Memorial Hospital, 2012* 69

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 70

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2012* 71

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2012* 72

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 73

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2012* 74

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2012* 75

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 76

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 77

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 78

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2012* 79

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2012* 80

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 81

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of British Columbia, 2012* 82

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Hospital, 2012* 83

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Korea Cancer Center Hospital, 2012* 84

List of Figures

Cervical Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8

Cervical Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9

Cervical Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10

Cervical Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11

Cervical Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12

Cervical Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13

Cervical Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 14

Cervical Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 15

Cervical Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16

Cervical Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 17

Cervical Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18

Cervical Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 19

Cervical Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20

Cervical Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21

Cervical Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22

Cervical Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23

Cervical Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 31

Cervical Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 32

Cervical Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 34

Cervical Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 36

GlobalData Methodology 113

$2500

Can be used by individual purchaser only

$7500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.